Photo taken from WHO Regional Office for Europe/LinkedIn
Jun 19, 2024, 07:18
WHO/Europe’s new landmark report on the Commercial Determinants of noncommunicable diseases – WHO Regional Office for Europe
Quoting WHO Regional Office for Europe on LinkedIn: .
“WHO/Europe’s new landmark report on the Commercial Determinants of noncommunicable diseases reveals the extent of harmful commercial practices and how they drive chronic diseases.
Resistance by industry to health protection policies has grown more sophisticated over time.
Public health professionals need new tools and skills to meet the commercial determinants challenge and safeguard public health.
A new cadre of public health professionals will:
- build coalitions around shared values of equity, sustainability and societal wellbeing
- understand economic and legal frameworks, including trade & investment agreements
- recognise common industry tactics like lobbying, targeted marketing, and misleading Corporate Social Responsibility initiatives
- develop mechanisms to enforce transparency and manage conflicts of interest
Read the full report here.”
cancer
chronic diseases
coalitions
Commercial Determinants of noncommunicable diseases
conflict of interest management
economic and legal frameworks
equity
harmful commercial practices
health protection policies
industry resistance
industry tactics
landmark report
lobbying
misleading CSR initiatives
new tools and skills
OncoDaily
Oncology
public health professionals
societal wellbeing
sustainability
targeted marketing
trade and investment agreements
transparency
WHO Regional Office for Europe
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 16, 2024, 21:08
Nov 16, 2024, 20:04
Nov 16, 2024, 20:00
Nov 16, 2024, 18:42
Nov 16, 2024, 17:57